Harmony Biosciences Holdings (HRMY) EBT Margin (2020 - 2026)
Harmony Biosciences Holdings' EBT Margin was 35.70% in Q2 2026, up 10.94 percentage points from 24.76% a year earlier and up 17.27 percentage points from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) EBT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Harmony Biosciences Holdings' EBT Margin was 25.13% through Jun 30, 2026, down 4.02 percentage points year-over-year; for FY2025, it was 24.76%, down 2.07 percentage points from FY2024.
- EBT Margin shows a five-year change of +47.89 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was 26.84% in FY2024 (-2.96 pp), 29.79% in FY2023 (+5.88 pp), 23.91% in FY2022 (+11.66 pp) and 12.25% in FY2021 (+35.38 pp).
- The Q2 2026 figure marks the highest quarterly EBT Margin in data going back to Q1 2020.
- Compared with a year earlier, EBT Margin was higher in four of the last eight quarters, with an average year-over-year change of -0.37 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q4 2021 (a gain of 27.20 percentage points); the worst was Q2 2024 (a drop of 20.30 percentage points).
- Per Business Quant data, HRMY's EBT Margin in the three quarters before Q2 2026 was 18.43% (Q1 2026), 16.72% (Q4 2025) and 28.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 35.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.70% |
| Mar 31, 2026 | 18.43% |
| Dec 31, 2025 | 16.72% |
| Sep 30, 2025 | 28.18% |
| Jun 30, 2025 | 24.76% |
| Mar 31, 2025 | 30.95% |
| Dec 31, 2024 | 27.90% |
| Sep 30, 2024 | 33.42% |
| Jun 30, 2024 | 12.55% |
| Mar 31, 2024 | 33.49% |
| Dec 31, 2023 | 23.57% |
| Sep 30, 2023 | 32.34% |
| Jun 30, 2023 | 32.85% |
| Mar 31, 2023 | 31.71% |
| Dec 31, 2022 | 34.37% |
| Sep 30, 2022 | 6.80% |
| Jun 30, 2022 | 27.31% |
| Mar 31, 2022 | 27.41% |
| Dec 31, 2021 | 26.83% |
| Sep 30, 2021 | -13.03% |
API Access
Harmony Biosciences Holdings EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();